An Exploratory, Randomized, Double-Blind, Crossover Study to Compare the Efficacy and Safety of BIIB074 Versus Placebo in the Treatment of Primary Inherited Erythromelalgia
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2017
At a glance
- Drugs Raxatrigine (Primary)
- Indications Erythromelalgia
- Focus Therapeutic Use
- Sponsors Convergence Pharmaceuticals
- 24 Jan 2017 Status changed from active, no longer recruiting to completed.
- 07 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 30 Sep 2016 New trial record